Mariner, LLC Gilead Sciences, Inc. Transaction History

Mariner, LLC

$51.1 Billion
Q2 2024

A detailed history of Mariner, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mariner, LLC holds 489,504 shares of GILD stock, worth $43.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

489,504

Previous 482,737 1.4%

Holding current value

$43.1 Million

Previous $35.4 Million 5.02%

% of portfolio

0.07%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $427,336 - $493,178	6,767 Added 1.4%	489,504 $33.6 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $22.4 Million - $27.3 Million	312,496 Added 183.56%	482,737 $35.4 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $116,352 - $131,946	-1,588 Reduced 0.92%	170,241 $13.8 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $88,062 - $96,077	1,191 Added 0.7%	171,829 $12.9 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $823,340 - $939,134	-10,832 Reduced 5.97%	170,638 $13.2 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $814,228 - $927,658	-10,532 Reduced 5.49%	181,470 $15 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $2.51 Million - $3.61 Million	40,339 Added 26.6%	192,002 $16.5 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $2.24 Million - $2.56 Million	37,667 Added 33.04%	151,663 $9.36 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $649,927 - $732,012	11,260 Added 10.96%	113,996 $7.05 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $250,098 - $313,400	4,318 Added 4.39%	102,736 $6.11 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $484,458 - $549,869	7,467 Added 8.21%	98,418 $7.15 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $170,849 - $184,327	2,524 Added 2.85%	90,951 $6.35 Million
Q2 2021 Aug 24, 2021	BUY	$63.47 - $69.35 $553,141 - $604,385	8,715 Added 10.93%	88,427 $6.09 Million
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $381,480 - $435,268	-6,358 Reduced 7.39%	79,712 $5.15 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $10.9 Million - $12.4 Million	-191,781 Reduced 69.02%	86,070 $5.01 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $3.07 Million - $3.86 Million	49,469 Added 21.66%	277,851 $17.6 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $5.33 Million - $6.19 Million	73,643 Added 47.59%	228,382 $17.6 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $1.39 Million - $1.78 Million	22,238 Added 16.78%	154,739 $11.6 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $904,027 - $994,400	14,671 Added 12.45%	132,501 $8.61 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $947,276 - $1.05 Million	-15,154 Reduced 11.4%	117,830 $7.47 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $28,088 - $31,498	-454 Reduced 0.34%	132,984 $8.98 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.56 Million - $1.75 Million	24,960 Added 23.01%	133,438 $8.68 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $462,283 - $603,244	7,636 Added 7.57%	108,478 $6.79 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $745,660 - $825,582	10,461 Added 11.57%	100,842 $7.79 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $895,863 - $1.04 Million	13,808 Added 18.03%	90,381 $6.4 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $3.76 Million - $4.59 Million	51,674 Added 207.53%	76,573 $5.77 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $1.9 Million - $2.23 Million	-26,644 Reduced 51.69%	24,899 $1.78 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $3.72 Million - $4.41 Million	51,543	51,543 $4.18 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account